Alterations in the human epidermal growth factor receptor 2 (HER2) gene, including mutations and amplifications, have been detected in some cases of lung adenocarcinoma and shown to be associated with aggressive tumor behavior and poor prognosis (3). The gene discussed is ERBB2; the disease is neoplasm.